Swelling at or near injection site: Case definition and guidelines for collection, analysis and presentation of immunization safety data

Vaccine

Volumn 25, Issue 31, 2007, Pages 5858-5874

  Kohl, Katrin S ^a   Walop, Wikke ^b   Gidudu, Jane ^a   Ball, Leslie ^c   Halperin, Scott ^d   Hammer, Sandra Jo ^e   Heath, Paul ^f   Varricchio, Frederick ^c   Rothstein, Edward ^g   Schuind, Anne ^h   Hennig, Renald ⁱ  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d DALHOUSIE UNIVERSITY   (Canada)

^e CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^g Pennridge Pediatric Associates   (United States)

^h GLAXOSMITHKLINE   (United States)

ⁱ Novartis Vaccine   (Germany)

Author keywords

Adverse event; Case definition; Guidelines; Immunization; Swelling

Indexed keywords

VACCINE;

ARTICLE; CASE DEFINITION; CASE STUDY; CLINICAL PRACTICE; CLINICAL RESEARCH; DATA ANALYSIS; DECISION MAKING; DRUG SAFETY; HUMAN; IMMUNIZATION; INJECTION SITE; INJECTION SITE SWELLING; OUTCOMES RESEARCH; PRACTICE GUIDELINE; PRIORITY JOURNAL; STANDARD;

ADVERSE DRUG REACTION REPORTING SYSTEMS; DATA COLLECTION; DATA INTERPRETATION, STATISTICAL; HUMANS; IMMUNIZATION; INJECTIONS; SAFETY; TERMINOLOGY;

EID: 34447252154     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.04.056     Document Type: Article

References (27)

1. Casey J.R., and Pichichero M.E. Acellular pertussis vaccine safety and efficacy in children, adolescents and adults. Rev Article Drugs 65 10 (2005) 1367-1389
2. Scheifele D.W., Halperin S.A., Rubin E., Tapiero B., Guasparini R., Meekison W., et al. Safety and immunogenicity of a pentavalent combination vaccine (diptheria, tetanus, acecullar pertussis, polio, and haemophilus influenzae type b conjugate) when administered as a fourth dose at 15 to 18 months of age. Hum Vaccines 1 (2005) 180-186
3. Jefferson T., Rudin M., and Pietrantonj S D. Adverse events after immunization with alumimium-containing DPT vaccines: systematic review of the evidence. Lancet 4 (2004) 84-90
4. Lee C.Y., Thipphawong J., Huang L.M., Lee P.I., Chiu H.H., Lin W., et al. An evaluation of the safety and immunogenicity of a five-component acellular pertusssis, diphtheria, and tetanus toxoid vaccine (DTaP) when combined with a Haemophilus influenzae Type b-Tetanus Toxoid conjugate vaccine (PRP-T) in Taiwanese infants. Pediatrics 103 (1999) 25-30
5. Mills E., Gold R., Thipphawong J., Barreto L., Guasparini R., Meekison W., et al. Safety and immunogenicity of a combined five-component pertussis-diphtheria-tetanus-inactivated poliomyelitis-Haemophilus b conjugate vaccine administered to infants at two, four, six months of age. Vaccine 16 (1998) 576-585
6. Nolan T., Hogg G., Darcy M.A., Carlin J.B., Skeljo M., and Varigos J. Immunogenicity and reactogenicity associated with an 18-month booster dose of a new diphtheria-tetanus-whole cell pertussis vaccine. J Pediatr Child Health 34 (1998) 346-348
7. Pichichero M.E., Deloria M.A., Rennels M.B., Anderson E.L., Edwards K.M., Decker M.D., et al. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pediatrics 100 (1997) 772-788
8. Ramsay M., Joce R., and Whalley J. Adverse events after school leavers received combined tetanus and low dose diphtheria vaccine. Commun Dis Rep CDR Rev 7 (1997) R65-R67
9. Scheifele D.W., Dobson S., Kallos A., Bjornson G., and Ochnio J.J. Comparative safety of tetanus-diphtheria toxoids booster immunization in students in Grades 6 and 9. Pediatr Infect Dis J 17 (1998) 1121-1126
10. West D.J., Hesley T.M., Jonas L.C., Feeley L.K., Bird S.R., Burke P., et al. Safety and immunogenicity of a bivalent Haemophilus influenzae type b/hepatitis B vaccine in healthy infants. Hib-HB Vaccine Study Group. Pediatr Infect Dis J 16 (1997) 593-599
11. Andre F.E., D'Hondt E., Delem A., and Safary A. Clinical assessment of the safety and efficacy of an inactivated hepatitis A vaccine: rationale and summary of findings. Vaccine 10 suppl. 1 (1992) S160-S168
12. Araujo O.O., Forleo-Neto E., Vespa G.N., Puccini R.F., Weckx L.W., Carvalho E.S., et al. Associated or combined vaccination of Brazilian infants with a conjugate Haemophilus influenzae type B (Hib) vaccine, a diphtheria-tetanus-whole-cell pertussis vaccine and IPV or OPV elicits protective levels of antibodies against Hib. Vaccine 19 (2001) 367-375
13. Blum M.D., Dagan R., Mendelman P.M., Pinsk V., Giordani M., Li S., et al. A comparison of multiple regimens of pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine and pneumococcal polysaccharide vaccine in toddlers. Vaccine 18 (2000) 2359-2367
14. Kohl K.S., Gidudu J., Bonhoeffer J., Braun M.M., Michael Buettcher M., Chen R.T., et al. The development of standardized case definitions and guidelines for adverse events following immunization. Vaccine 25 (2007) 5671-5674
15. Rothstein E., et al. Nodule at injection site as an adverse event following immunization: case definition and guidelines for data collection, analysis, and presentation. Vaccine 22 (2004) 575-585
16. Pichichero M.E., Edwards K.M., Anderson E.L., Rennels M.B., Englund J.A., Yerg D.E., et al. Safety and immunogenicity of six acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fifth dose in four- to six-year-old children. Pediatrics 105 (2000) e11
17. Rennels M.B., Deloria M.A., Pichichero M.E., Losonsky G.A., Englund J.A., Meade B.D., et al. Extensive swelling after booster doses of acellular pertussis-tetanus-diphtheria vaccines. Pediatrics 105 (2000) e12
18. Schmitt H.J., Beutel K., Schuind A., Knuf M., Wagner S., Muschenborn S., et al. Reactogenicity and immunogenicity of a booster dose of a combined diphtheria, tetanus, and tricomponent acellular pertussis vaccine at fourteen to twenty-eight months of age. J Pediatr 130 (1997) 616-623
19. Blennow M., and Granström A. Adverse reactions after diphtheria-tetanus booster in 10-year-old schoolchildren in relation to the type of vaccine given for the primary vaccination. Vaccine 12 (1994) 427-430
20. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH), Guidelines for Clinical Safety assessment (E2a-e). Available on the world wide web: http://www.ich.org/ [last accessed February 9, 2006].
21. Council for International Organizations of Medical Sciences (CIOMS), Reporting form for International Reporting of Adverse Drug Reactions. Available on the world wide web: http://www.cioms.ch/frame_what_is_cioms.htm [last accessed February 9, 2006].
22. CDC. Guidelines for maintaining and managing the vaccine cold chain. MMWR 2003;52:1023-5. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5242a6.htm [Last accessed January, 26, 2007].
23. CDC. General Recommendations on Immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2006;55(RR 15):1-48. Also available at: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5515a1.htm [Last accessed January, 26, 2007].
24. CDC. Use of diphtheria toxoid-tetanus toxoid-acellular pertussis vaccine as a five-dose series. Supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2000;49(RR13):1-8.
25. The CONSORT statement, revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285(15):1987-91. Available on the world wide web: http://www.consort-statement.org/Statement/revisedstatement.htm [last accessed February 9, 2006].
26. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet 1999;354(November (9193)):1896-900. Available on the world wide web: http://www.consort-statement.org/Initiatives/complements.htm [last accessed February 9, 2006].
27. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Moher D, Becker BJ, Sipe TA, Thacker SB. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000; 283(15):2008-12. Available on the world wide web: http://www.consort-statement.org/Initiatives/complements.htm [last accessed February 9, 2006].